Unbesiegt vs. Unzerbrechlich ATHEN, Griechenland, 5. Februar 2026 /PRNewswire/ — Floyd „Money” Mayweather Jr., der erfolgreichste und unbesiegte Boxer der Geschichte, wird in Athen in den Ring steigen, dem Geburtsort der Olympischen Spiele und dem Fundament des globalen Sports. Am 27. Juni 2026 steht Mayweather im Mittelpunkt von BATTLE OF THE LEGENDS, einem globalen Mega-Event, und… Continue reading Floyd Mayweather tritt in Athen bei BATTLE of the LEGENDS gegen die griechische Ikone Mike Zambidis an
Category: Newswire
The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend
Total revenues for 2025 increased 11% to $274.9 billion Shareholders’ net income for 2025 was $6.0 billion, or $22.18 per share Adjusted income from operations1 for 2025 was $8.0 billion, or $29.84 per share 2026 adjusted income from operations1 is projected to be at least $7.950 billion, or at least $30.25 per share2 Board of… Continue reading The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend
Floyd Mayweather se enfrenta al icono griego ‘Iron’ Mike Zambidis en Atenas en BATTLE of the LEGENDS
Invicto vs inquebrantable ATENAS, Grecia, 5 de febrero de 2026 /PRNewswire/ — Floyd “Money” Mayweather Jr., el boxeador más exitoso e invicto de la historia, subirá al ring en Atenas, cuna de los Juegos Olímpicos y base misma del deporte mundial. El 27 de junio de 2026, Mayweather encabezará BATTLE OF THE LEGENDS, un megaevento mundial,… Continue reading Floyd Mayweather se enfrenta al icono griego ‘Iron’ Mike Zambidis en Atenas en BATTLE of the LEGENDS
PhotonPharma Inc. Announces Recruitment for Phase 1 Clinical Trial of Innocell™ Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer
FORT COLLINS, Colo., Feb. 5, 2026 /PRNewswire/ — PhotonPharma Inc., a biopharmaceutical company pioneering personalized cancer immunotherapies, today announced that patient recruitment has opened for its Phase 1 clinical trial evaluating Innocell™ in patients with recurrent epithelial ovarian cancer. The trial for Innocell, the investigational product, is registered with ClinicalTrials.gov under identifier NCT06366490. The clinical… Continue reading PhotonPharma Inc. Announces Recruitment for Phase 1 Clinical Trial of Innocell™ Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer
APEXX Global Announces $10 million Investment from Finch Capital to Accelerate Global Growth
LONDON, Feb. 5, 2026 /PRNewswire/ — APEXX Global, the leading merchant-centric Payment Orchestration Platform, today announced a strategic investment of up to $10 million USD led by Finch Capital, a European growth investor with deep expertise in payments and scaling financial technology players internationally. APEXX Global is a multi award-winning Payment Orchestration Platform enabling enterprise… Continue reading APEXX Global Announces $10 million Investment from Finch Capital to Accelerate Global Growth
Inventory Gains Slow Down in January: Realtor.com® Monthly Housing Report
Active listings rose from last year but slipped to 17.2% below 2017–2019 norms; the widest gap since last spring, as prices held steady nationally AUSTIN, Texas, Feb. 5, 2026 /PRNewswire/ — U.S. housing supply continued to grow this January, but the recovery lost momentum as inventory moved further away from pre-pandemic norms, according to Realtor.com®‘s January… Continue reading Inventory Gains Slow Down in January: Realtor.com® Monthly Housing Report
Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
Financial release and supplemental presentation accessible online BOSTON, Feb. 5, 2026 /PRNewswire/ — Haemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal year 2026, which ended December 27, 2025, are available on the Company’s Investor Relations website at www.haemonetics.com. The Company will host a conference call and webcast with investors and… Continue reading Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
Carrier Reports 2025 Results and Announces 2026 Outlook
Fourth Quarter 2025 Results Net sales down 6%; organic sales down 9% GAAP EPS from continuing operations of $0.03 and adjusted EPS of $0.34 Net cash flows from operating activities were $1,040 million and free cash flow was $909 million Full Year 2025 Results Sales of $21.75 billion, down 3% compared to 2024, organic sales… Continue reading Carrier Reports 2025 Results and Announces 2026 Outlook
APEXX Global Announces $10 million Investment from Finch Capital to Accelerate Global Growth
LONDON, Feb. 5, 2026 /PRNewswire/ — APEXX Global, the leading merchant-centric Payment Orchestration Platform, today announced a strategic investment of up to $10 million USD led by Finch Capital, a European growth investor with deep expertise in payments and scaling financial technology players internationally. APEXX Global is a multi award-winning Payment Orchestration Platform enabling enterprise… Continue reading APEXX Global Announces $10 million Investment from Finch Capital to Accelerate Global Growth
Coldstream Continues Strategic Expansion in the Pacific Northwest with New Office and Team in Bend, Oregon
Krista Charlton, CFP®, joins firm to enhance regional client service capabilities SEATTLE, Feb. 5, 2026 /PRNewswire/ — Coldstream announced today that it has opened a new office in Bend, Oregon. Coldstream Chief Client Experience Officer and member of the firm’s Board of Directors, Anne Marie Stonich, CFP®, CPA, will oversee the firm’s continued expansion in… Continue reading Coldstream Continues Strategic Expansion in the Pacific Northwest with New Office and Team in Bend, Oregon